Search research articles
Contact Us
Filters
Showing results (481-490 of 501) with videos related to
Page
of 51
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 20, 2024
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
Neil R Aggarwal, Jacquie Nordwall, Dominique L Braun, et al.
Science Immunology
|
July 18, 2025
Tissue origin and virus specificity shape human CD8<sup>+</sup> T cell cytotoxicity
Julia Niessl, Thomas R Müller, Christian Constantz, et al.
Nature Immunology
|
October 13, 2020
Two subsets of stem-like CD8<sup>+</sup> memory T cell progenitors with distinct fate commitments in humans
Giovanni Galletti, Gabriele De Simone, Emilia M C Mazza, et al.
The Journal of Experimental Medicine
|
December 25, 2016
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency
Hassan Abolhassani, Emily S J Edwards, Aydan Ikinciogullari, et al.
Nature Immunology
|
March 14, 2018
T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids
Kwok S Wun, Josephine F Reijneveld, Tan-Yun Cheng, et al.
Journal of Medicinal Chemistry
|
November 2, 2022
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
Kentaro Futatsugi, Shawn Cabral, Daniel W Kung, et al.
The Journal of Clinical Investigation
|
February 21, 2018
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1
Maureen P Martin, Vivek Naranbhai, Patrick R Shea, et al.
Lancet (London, England)
|
December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Guy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Journal of Medicinal Chemistry
|
August 19, 2020
Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting
Kim Huard, Aaron C Smith, Gregg Cappon, et al.
Nature Immunology
|
September 18, 2023
Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Amy D Proal, Michael B VanElzakker, Soo Aleman, et al.
Page
of 51
Search research articles
Search
Showing results (481-490 of 501) with videos related to
Sort By:
Page
of 51
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 20, 2024
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
Neil R Aggarwal, Jacquie Nordwall, Dominique L Braun, et al.
Science Immunology
|
July 18, 2025
Tissue origin and virus specificity shape human CD8<sup>+</sup> T cell cytotoxicity
Julia Niessl, Thomas R Müller, Christian Constantz, et al.
Nature Immunology
|
October 13, 2020
Two subsets of stem-like CD8<sup>+</sup> memory T cell progenitors with distinct fate commitments in humans
Giovanni Galletti, Gabriele De Simone, Emilia M C Mazza, et al.
The Journal of Experimental Medicine
|
December 25, 2016
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency
Hassan Abolhassani, Emily S J Edwards, Aydan Ikinciogullari, et al.
Nature Immunology
|
March 14, 2018
T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids
Kwok S Wun, Josephine F Reijneveld, Tan-Yun Cheng, et al.
Journal of Medicinal Chemistry
|
November 2, 2022
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
Kentaro Futatsugi, Shawn Cabral, Daniel W Kung, et al.
The Journal of Clinical Investigation
|
February 21, 2018
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1
Maureen P Martin, Vivek Naranbhai, Patrick R Shea, et al.
Lancet (London, England)
|
December 19, 2017
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Guy E Thwaites, Matthew Scarborough, Alexander Szubert, et al.
Journal of Medicinal Chemistry
|
August 19, 2020
Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting
Kim Huard, Aaron C Smith, Gregg Cappon, et al.
Nature Immunology
|
September 18, 2023
Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Amy D Proal, Michael B VanElzakker, Soo Aleman, et al.
Page
of 51